Bayesian Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-14,100
| Closed | -$19.5K | – | 653 |
|
|
2024
Q4 | $19.5K | Buy |
+14,100
| New | +$19.5K | ﹤0.01% | 644 |
|
|
2024
Q2 | – | Sell |
-23,559
| Closed | -$56.3K | – | 785 |
|
|
2024
Q1 | $56.3K | Buy |
+23,559
| New | +$56.3K | 0.01% | 732 |
|
|
2023
Q1 | – | Sell |
-23,800
| Closed | -$188K | – | 823 |
|
|
2022
Q4 | $188K | Buy |
+23,800
| New | +$188K | 0.03% | 611 |
|
|
2020
Q1 | – | Sell |
-10,536
| Closed | -$190K | – | 796 |
|
|
2019
Q4 | $190K | Buy |
+10,536
| New | +$190K | 0.03% | 540 |
|
|
2018
Q2 | – | Sell |
-19,600
| Closed | -$217K | – | 611 |
|
|
2018
Q1 | $217K | Buy |
+19,600
| New | +$217K | 0.06% | 480 |
|